Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

ver descrição completa

Detalhes bibliográficos
Principais autores:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Formato:	Artigo
Idioma:	Russian
Publicado em:	«FIRMA «SILICEA» LLC 2004-12-01
coleção:	Российский кардиологический журнал
Assuntos:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Acesso em linha:	https://russjcardiol.elpub.ru/jour/article/view/2326

Registros relacionados

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
por: S. V. Nedogoda, et al.
Publicado em: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
por: P. P. Tikhonov, et al.
Publicado em: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
por: S. V. Nedogoda, et al.
Publicado em: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
por: S. I. Drozdetsky, et al.
Publicado em: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
por: A. P. Kondrakhin, et al.
Publicado em: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
por: E. V. Eliseeva, et al.
Publicado em: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
por: Y. R. Kasherininov, et al.
Publicado em: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
por: Mehmet Burak Yalçın, et al.
Publicado em: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
por: Osman Kukula, et al.
Publicado em: (2024-02-01)

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
por: Nirma D. Perera, et al.
Publicado em: (2021-07-01)

Main results of the Russian trial «ALTAIR»
por: E. V. Shlyakhto, et al.
Publicado em: (2006-02-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
por: Monique L Parkin, et al.
Publicado em: (2016-11-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
por: N. N. Nikitina, et al.
Publicado em: (2015-12-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
por: V. Estato, et al.
Publicado em: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
por: L. A. Khaisheva, et al.
Publicado em: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
por: V. I. Makolkin
Publicado em: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
por: András Érszegi, et al.
Publicado em: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
por: L. I. Markova, et al.
Publicado em: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
por: V. A. Nevzorova, et al.
Publicado em: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
por: I. E. Chazova, et al.
Publicado em: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
por: I. N. Medvedev, et al.
Publicado em: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
por: I. N. Medvedev, et al.
Publicado em: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
por: I. N. Medvedev, et al.
Publicado em: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
por: I. N. Medvedev, et al.
Publicado em: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
por: A. P. Vasilyev, et al.
Publicado em: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
por: A. N. Britov, et al.
Publicado em: (2006-06-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
por: E. G. Ivanova, et al.
Publicado em: (2023-04-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
por: N. J. Gromnazky, et al.
Publicado em: (2003-12-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
por: G. N. Gorokhovskaya, et al.
Publicado em: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
por: L. I. Abasova, et al.
Publicado em: (2011-08-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
por: M. M. Beraya, et al.
Publicado em: (2007-02-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
por: E. G. Ivanova, et al.
Publicado em: (2022-07-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
por: A S Ryazanov, et al.
Publicado em: (2003-03-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
por: M. M. Beraya, et al.
Publicado em: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
por: E. V. Tishina, et al.
Publicado em: (2011-06-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
por: Michał Łata, et al.
Publicado em: (2025-01-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
por: V. V. Trusov, et al.
Publicado em: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
por: Roman A. Yaskevich, et al.
Publicado em: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
por: Roman A. Yaskevich, et al.
Publicado em: (2022-06-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
por: I. S. Dzherieva, et al.
Publicado em: (2015-12-01)